9 Meters Biopharma (NMTR) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock NMTR vs. CMND, TTNP, EVOK, PLRZ, NBY, CANF, LIPO, ONVO, SXTP, and PALIShould you be buying 9 Meters Biopharma stock or one of its competitors? The main competitors of 9 Meters Biopharma include Clearmind Medicine (CMND), Titan Pharmaceuticals (TTNP), Evoke Pharma (EVOK), Polyrizon (PLRZ), NovaBay Pharmaceuticals (NBY), Can-Fite BioPharma (CANF), Lipella Pharmaceuticals (LIPO), Organovo (ONVO), 60 Degrees Pharmaceuticals (SXTP), and Palisade Bio (PALI). These companies are all part of the "pharmaceutical products" industry. 9 Meters Biopharma vs. Its Competitors Clearmind Medicine Titan Pharmaceuticals Evoke Pharma Polyrizon NovaBay Pharmaceuticals Can-Fite BioPharma Lipella Pharmaceuticals Organovo 60 Degrees Pharmaceuticals Palisade Bio 9 Meters Biopharma (NASDAQ:NMTR) and Clearmind Medicine (NASDAQ:CMND) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations and media sentiment. Does the media prefer NMTR or CMND? In the previous week, Clearmind Medicine had 3 more articles in the media than 9 Meters Biopharma. MarketBeat recorded 3 mentions for Clearmind Medicine and 0 mentions for 9 Meters Biopharma. Clearmind Medicine's average media sentiment score of 0.74 beat 9 Meters Biopharma's score of 0.00 indicating that Clearmind Medicine is being referred to more favorably in the news media. Company Overall Sentiment 9 Meters Biopharma Neutral Clearmind Medicine Positive Is NMTR or CMND more profitable? Clearmind Medicine's return on equity of -164.79% beat 9 Meters Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets 9 Meters BiopharmaN/A -584.97% -159.45% Clearmind Medicine N/A -164.79%-71.12% Which has preferable earnings & valuation, NMTR or CMND? Clearmind Medicine is trading at a lower price-to-earnings ratio than 9 Meters Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio9 Meters BiopharmaN/AN/A-$43.77M-$3.46N/AClearmind MedicineN/AN/A-$5.26M-$1.10-0.89 Do institutionals & insiders believe in NMTR or CMND? 22.3% of 9 Meters Biopharma shares are held by institutional investors. Comparatively, 96.1% of Clearmind Medicine shares are held by institutional investors. 2.4% of 9 Meters Biopharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more risk & volatility, NMTR or CMND? 9 Meters Biopharma has a beta of 1.36, suggesting that its share price is 36% more volatile than the S&P 500. Comparatively, Clearmind Medicine has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. SummaryClearmind Medicine beats 9 Meters Biopharma on 7 of the 10 factors compared between the two stocks. Get 9 Meters Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for NMTR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NMTR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NMTR vs. The Competition Export to ExcelMetric9 Meters BiopharmaBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.04M$131.03M$5.51B$9.31BDividend YieldN/A3.74%4.25%4.09%P/E Ratio-0.023.6028.1219.69Price / SalesN/A4,246.15439.46100.25Price / CashN/A13.1935.5357.53Price / BookN/A42.108.235.67Net Income-$43.77M-$92.15M$3.23B$257.51M 9 Meters Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NMTR9 Meters BiopharmaN/AN/AN/AN/A$1.04MN/A-0.0220CMNDClearmind Medicine0.8871 of 5 stars$0.96-3.2%N/A-46.4%$4.09MN/A-0.87N/ATTNPTitan Pharmaceuticals0.3127 of 5 stars$4.43+0.6%N/A-8.8%$4.04MN/A-0.9610EVOKEvoke Pharma0.8189 of 5 stars$2.61-1.5%N/A-28.8%$3.89M$10.25M-0.914Gap DownPLRZPolyrizonN/A$0.72+2.9%N/AN/A$3.82MN/A0.00N/ANBYNovaBay Pharmaceuticals1.5824 of 5 stars$0.63-4.8%$0.85+34.7%-69.8%$3.67M$9.78M-0.0130CANFCan-Fite BioPharma2.5247 of 5 stars$1.03+0.5%$14.00+1,265.9%-71.4%$3.63M$674K-0.578LIPOLipella Pharmaceuticals1.6307 of 5 stars$0.78-8.1%N/A-80.1%$3.49M$536.36K-0.194Gap DownONVOOrganovoN/AN/AN/AN/A$3.47M$122K-2.4020Gap UpSXTP60 Degrees Pharmaceuticals2.6917 of 5 stars$2.37+1.7%$7.00+195.5%+40.2%$3.46M$665.45K-0.053News CoverageGap DownPALIPalisade Bio2.7075 of 5 stars$0.70-4.4%$12.00+1,609.4%-83.0%$3.39M$250K-0.1010 Related Companies and Tools Related Companies CMND Alternatives TTNP Alternatives EVOK Alternatives PLRZ Alternatives NBY Alternatives CANF Alternatives LIPO Alternatives ONVO Alternatives SXTP Alternatives PALI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NMTR) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 9 Meters Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 9 Meters Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NMTR Stock Alerts